Local ethic review board (Fujian Cancer Hospital) approved the study (No. K2024-286-01), and patient informed consent was deemed unnecessary, given its retrospective nature. Fig 1. Study profile for ...

Tevimbra is under clinical development by BeiGene and currently in Phase III for Nasopharyngeal Cancer. According to GlobalData, Phase III drugs for Nasopharyngeal Cancer have a 67% phase transition ...

Objectives: Patients with nasopharyngeal carcinoma (NPC) are prone to malnutrition, which leads to deterioration of health. This study is to clarify the effect of Artificial intelligence (AI)-assisted ...

Background: Hypothyroidism is a common sequela after radiotherapy for nasopharyngeal carcinoma (NPC). Magnetic resonance imaging (MRI) has gained prominence in thyroid imaging, leveraging its ...

Objectives This study delineates the global nasopharyngeal carcinoma’s (NPC) incidence and mortality across 185 countries in 2020 and projects the disease’s burden by 2040. Design A prediction study.

1GuangDong Provincial Key Laboratory of Tumor Immunotherapy, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

李振彰博士团队的研究方法使用了深度学习算法，通过训练模型，使其能够从海量内窥镜图像中学习并识别出可能的癌症病变。这一过程不仅提升了早期诊断的准确性，也大大降低了对专业医疗设备的依赖，为基层医疗提供了更加便捷和可及的解决方案。

But knowing your risk can help you watch for signs of cancer, especially if you have more than one risk factor. Watching for signs of nasopharyngeal cancer if you have had mono New research has shown ...

Cash-strapped Viracta Therapeutics is continuing to reduce its options in order to stay afloat. Less than two months after ...